Phibro Animal Health (PAHC) Misses Q2 EPS by 2c, Offers Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- Alphabet added to Dow Jones Industrial Average, Verizon dropped
- Chip stocks plunge, but bargain-hunters limit scale of tech rout
- FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
- Oil prices finish 1% lower as investors focus on Hormuz flows after peace talks
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Needham Starts NeoVolta (NEOV) at Buy
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
Phibro Animal Health Corporation Reports Third Quarter Results, Provides Revised Financial Guidance
May 4, 2022 4:25 PM EDTTEANECK, N.J.--(BUSINESS WIRE)-- Phibro Animal Health Corporation (Nasdaq: PAHC) today announced financial results for its third quarter ended March 31, 2022.
Highlights for the three months ended March 31, 2022 (compared to the three months ended March 31, 2021) Net sales of $239.6 million, an increase of $27.9 million, or 13% Net income of $17.7 million, an increase of $5.5 million, or 45% Diluted EPS of $0.44, an increase of $0.14 or 47% Adjusted EBITDA of $28.0 million, comparable to the prior year Adjusted Net Income of $13.4 million, a decrease of $0.5 million, or... More